Litcius/Paper detail

Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial

Randolph P. Matthews, Munjal Patel, Stephanie E. Barrett, Liesbeth Haspeslagh, Tom Reynders, Saijuan Zhang, Sylvie Rottey, Adrian P. Goodey, Ryan Vargo, Jay A. Grobler, S. Aubrey Stoch, Marian Iwamoto

2021Nature Medicine69 citationsDOI

Topics & Concepts

PharmacokineticsPlaceboMedicineTolerabilityPeripheral blood mononuclear cellAdverse effectReverse-transcriptase inhibitorPharmacologyImplantInternal medicineGastroenterologySurgeryHuman immunodeficiency virus (HIV)ImmunologyViral loadChemistryAntiretroviral therapyPathologyIn vitroBiochemistryAlternative medicineHIV/AIDS drug development and treatmentHIV Research and TreatmentHIV/AIDS Research and Interventions
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial | Litcius